Barclays Maintains an 'Overweight' on Covidien Ltd (COV); Is This Your First Time?
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Covidien (COV) Gets FDA 510(k) Clearance for LigaSure
September 11, 2012 7:03 AM EDTCovidien (NYSE: COV) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat (ENT) procedures. When working in confined surgical... More
NxStage (NXTM) Taps Covidien's (COV) Todd Snell as QA SVP
September 10, 2012 8:38 AM EDTNxStage Medical, Inc. (Nasdaq: NXTM), announced Todd M. Snell has joined the Company as Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs.
Snell brings to NxStage more than 20 years of quality and operational leadership experience with over 13 years in the healthcare industry,... More
